TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Scanbio Ingredients AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
71,310
|
62,439
|
50,512 |
Financial expenses |
10,540
|
7,918
|
6,453 |
Earnings before taxes |
10,079
|
-2,027
|
1,411 |
Total assets |
51,073
|
35,550
|
35,148 |
Current assets |
39,142
|
21,257
|
17,329 |
Current liabilities |
17,589
|
15,814
|
15,685 |
Equity capital |
33,418
|
19,736
|
19,347 |
- share capital |
22,610
|
23,863
|
22,634 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
65.4%
|
55.5%
|
55.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
14.1%
|
-3.2%
|
2.8% |
Return on assets (ROA) |
40.4%
|
16.6%
|
22.4% |
Current ratio |
222.5%
|
134.4%
|
110.5% |
Return on equity (ROE) |
30.2%
|
-10.3%
|
7.3% |
Change turnover |
12,151
|
9,183
|
1,981 |
Change turnover % |
21%
|
17%
|
4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.